Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Texas Southwestern Medical Center
About this trial
The goals of this study are: 1) to identify biomarkers using neuroimaging that are associated with progression rate using statistical methods, and 2) to identify biomarkers that are associated with the differential diagnosis of Parkinson's disease and atypical parkinsonism.
Eligibility criteria
Qualifiers
Diagnosis of Parkinson disease
Existence of sufficient clinical data from previous UTS Southwestern longitudinal study to determine progression rate (categorized as fast or slow)
Availability of suitable matched participant in the alternate progression group (fast or slow)
Willingness to participate in the imaging studies required for this study and to provide written informed consent
Disqualifiers
Any contraindications to undergoing the multimodal imaging program
All females of child-bearing potential, between the ages of 18-55, will be excluded from the study, unless they are confirmed to be not pregnant with a pregnancy test prior to scanning
This study will require constant clear communication throughout the duration of the study; therefore, non-English speakers will be excluded
Right-handed finger amputees
Trial design
Treatments tested in this trial
- Not listed
Trial groups
90 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov